Last reviewed · How we verify

amosartan and rosuvastatin

Hanmi Pharmaceutical Company Limited · Phase 1 active Small molecule

amosartan and rosuvastatin is a Small molecule drug developed by Hanmi Pharmaceutical Company Limited. It is currently in Phase 1 development. Also known as: amosartan and rosuvastatin, P.O.

At a glance

Generic nameamosartan and rosuvastatin
Also known asamosartan and rosuvastatin, P.O
SponsorHanmi Pharmaceutical Company Limited
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about amosartan and rosuvastatin

What is amosartan and rosuvastatin?

amosartan and rosuvastatin is a Small molecule drug developed by Hanmi Pharmaceutical Company Limited.

Who makes amosartan and rosuvastatin?

amosartan and rosuvastatin is developed by Hanmi Pharmaceutical Company Limited (see full Hanmi Pharmaceutical Company Limited pipeline at /company/hanmi-pharmaceutical-company-limited).

Is amosartan and rosuvastatin also known as anything else?

amosartan and rosuvastatin is also known as amosartan and rosuvastatin, P.O.

What development phase is amosartan and rosuvastatin in?

amosartan and rosuvastatin is in Phase 1.

Related